InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.84
(
0.18%
)
US TECH 100
19,283.60
(
0.36%
)
Dow Jones
39,245.69
(
0.30%
)
Brent Oil
85.28
(
0.95%
)
Bitcoin
62,022.50
(
1.99%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DonShimoda

Send PM Follow Ignore
Followers 19
Posts 727
Boards Moderated 0
Alias Born 11/10/2009

DonShimoda

Re: None

Thursday, 05/05/2011 10:47:33 AM

Thursday, May 05, 2011 10:47:33 AM

Post# of 80490
My guess is that we'll see the 113 IND filed around the time of the Amsterdam conference. What's even more exciting is that Berger confirmed the trial would use biomarkers to screen/enroll only those pts with ALK mutations. This would be like running a Ponatinib trial with only T3151 pts...and we know how great that would turn out.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up